Global Tissue Engineered Skin Substitutes Market, By Duration (Permanent, Semi- Permanent), Anatomical Structure (Cellular, Acellular), Biomaterial (Autologous, Allogeneic, Xenogeneic, Others), Technology (Laser assisted bio-printing, 3D, Robotic technology, Others), Application (Chronic wounds, Burns Cases, Traumatic wounds, Diabetic Foot Ulcers, Others), End- Users (Hospitals, Other Healthcare Facilities), Type (Synthetic Skin Substitute, Biosynthetic Skin Substitute, Biological Skin Substitute, Allograft, Xenograft, Acellular Skin Substitute, Acellular Skin Substitute Based on Amniotic Membrane, Cellular Skin Substitute, Cellular Skin Substitute Based on Amniotic Membrane, Others) – Industry Trends and Forecast to 2029
Market Analysis and Size
The tissue engineered skin substitutes market is anticipated to witness significant growth over the forecast period. The market is being propelled forward by various growth determinants and is expected to continue to expand across the globe with the same pace as there are growing cases which require tissue engineered skin substitutes.
- Data Bridge Market Research analyses that the tissue engineered skin substitutes market is expected to grow at a CAGR of 14.90% during the forecast period. The “chronic wounds” accounts for the largest application segment in the tissue engineered skin substitutes market within the forecasted period.
Market Definition
Skin substitutes are the simplest of the tissue-engineered organ constructs, and have been used for testing commercial products, therapeutics, and as models of skin biology and pathology for many years. They are based on the ability of fibroblasts and keratinocytes to spontaneously form a skin-like structure, but they've been expanded to include other cell types to provide models of intact skin's wide range of properties. The tissue engineered skin substitute market includes the commercial production of these constructs, especially for therapeutic purposes.
Tissue Engineered Skin Substitutes Market Dynamics
Drivers
-
Growing Associated Diseases
The growing diseases such as the increasing instances of obesity and patients suffering from diabetic and vascular ulcers are the most significant factor driving the growth for this market. Moreover, the increasing prevalence of acute and chronic wounds along with the growing burn and trauma cases are expected to accelerate the overall growth of the market.
The growing demand for minimally invasive procedures and increasing burn injuries and vascular diseases are projected to cushion he growth of the market. Moreover, the increasing government investment along with the rising awareness among the patients and doctors are also expected to fuel market growth. Moreover, the rising disposable income which leads to the improvement in the healthcare infrastructure also cushions the market’s growth within the forecasted period.
Opportunities
Furthermore, the ability of tissue engineering to replace conventional auto and allografts extend profitable opportunities to the market players in the forecast period of 2022 to 2029. Moreover, rising focus on technological advancements will further expand the tissue engineered skin substitutes market's growth rate in the future.
Restraints/Challenges
On the other hand, large skin defects resulting from burns, trauma, congenital giant nevi, and disease can lead to skin necrosis to achieving skin coverage is expected to obstruct market growth. Stringent rules and regulations across the world concerning ambiguities associated with the environment are projected to hamper the overall growth of the market. Also, the lack of feasible reimbursement policies and inability of reproducing skin appendages are projected to challenge the tissue engineered skin substitutes market in the forecast period of 2022-2029.
This tissue engineered skin substitutes market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the tissue engineered skin substitutes market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Tissue Engineered Skin Substitutes Market
The sudden outbreak of the COVID-19 had a negative impact on the market. Due to the lockdown and social distancing norms, major corporations have halted operations in various locations which hampered the growth of the market. However, the pandemic also requires the tissue engineers to aid amidst viral outbreak. There is a high need for improvements in diagnostics and therapeutics. Because of their ability to apply engineering principles to biological processes, experience in collaborative environments, and penchant for technological translation from benchtop to bedside, the tissue engineering has high potential to have a significant impact on clinical outcomes in viral outbreaks if mobilized.
Recent Developments
- In September 2020, Acelity and Scapa Healthcare have reached an agreement to transition Systagenix's manufacturing facility. For competing in the market this transaction will increase focus on innovation, development, and commercialization of an expanded advanced wound dressing's portfolio.
- On December 16, 2020, Integra LifeSciences Holdings Corporation, a leading global medical technology company, announced that it has signed a definitive agreement to buy ACell, Inc. ("ACell") for $300 million in cash at closing, subject to customary purchase price adjustments, and up to another $100 million in cash if certain revenue growth milestones are met.
Global Tissue Engineered Skin Substitutes Market Scope
The tissue engineered skin substitutes market is segmented on the basis of duration, anatomical structure, biomaterial, technology, application, end users and type. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Duration
- Permanent
- Semi- Permanent
On the basis of duration, the tissue engineered skin substitutes market is segmented into permanent and semi- permanent.
Anatomical Structure
- Cellular
- Acellular
The anatomical structure segment of the tissue engineered skin substitutes market is divided into cellular and acellular.
Biomaterial
- Autologous
- Allogeneic
- Xenogeneic
- Others
On the basis of biomaterial, the tissue engineered skin substitutes market is segmented into autologous, allogeneic, xenogeneic and others.
Technology
- Laser assisted bio-printing
- 3D
- Robotic Technology
- Others
On the basis of level of technology, the tissue engineered skin substitutes market is segmented into laser assisted bio-printing, 3D, robotic technology and others.
Application
- Chronic wounds
- Burns Cases
- Traumatic wounds
- Diabetic Foot Ulcers
- Others
Application segment of the tissue engineered skin substitutes market is divided into chronic wounds, burns cases, traumatic wounds, diabetic foot ulcers and others. Chronic wounds are estimated to be the largest segment in the application within the market.
End- Users
- Hospitals
- Other Healthcare Facilities
On the basis of end- users, the market is divided into hospitals and other healthcare facilities.
Type
- Synthetic Skin Substitute
- Biosynthetic Skin Substitute
- Biological Skin Substitute
- Allograft
- Xenograft
- Acellular Skin Substitute
- Acellular Skin Substitute
- Based on Amniotic Membrane
- Cellular Skin Substitute
- Cellular Skin Substitute Based on Amniotic Membrane
- Others
Type segment of the tissue engineered skin substitutes market is divided into synthetic skin substitute, biosynthetic skin substitute, biological skin substitute, allograft and xenograft, acellular skin substitute, acellular skin substitute based on amniotic membrane, cellular skin substitute, cellular skin substitute based on amniotic membrane and others. Allograft is further segmented into cellular allograft and acellular allograft.
Tissue Engineered Skin Substitutes Market Regional Analysis/Insights
The tissue engineered skin substitutes market is analyzed and market size insights and trends are provided by country, duration, anatomical structure, biomaterial, technology, application, end users and type as referenced above.
The countries covered in the tissue engineered skin substitutes market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the tissue engineered skin substitutes market because of the technological advancements in the healthcare sector, availability of skilled professionals, rising number of burn injuries and the presence of several key players within the region. Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the increase in demand for tissue engineered skin substitutes, rapidly growing medical tourism industry and the increase in medical approvals along with presence of developing countries such as China, India, and Japan in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The tissue engineered skin substitutes market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for tissue engineered skin substitutes market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the tissue engineered skin substitutes market. The data is available for historic period 2010-2020.
Competitive Landscape and Tissue Engineered Skin Substitutes Market Share Analysis
The tissue engineered skin substitutes market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to tissue engineered skin substitutes market.
Some of the major players operating in the tissue engineered skin substitutes market are Smith+Nephew, Mölnlycke Health Care AB, Integra LifeSciences, Regenicin., Organogenesis Inc, MiMedx., LifeNet Health, Kerecis, Medline Industries, Inc, Essity Medical Solutions, ConvaTec Group PLC, Mallinckrodt, Abbott, Solvay, Olympus Corporation, Terumo Corporation, Berkeley Advanced Biomaterials, Avery Therapeutics, Inc., Biomimetic Solutions, The Lubrizol Corporation, CRS Holdings Inc., CAM Bioceramics B.V., Zimmer Biomet, Wright Medical Group N.V, GELITA AG , Tissue Regenix, and AMARANTUS BIOSCIENCE HOLDINGS, INC., among others.
SKU-